Infections and Head Trauma: New Clues in Alzheimer's Disease Risk
A Yale study suggests that SARS-CoV-2 can induce amyloid beta buildup in retinal tissue, which is associated with Alzheimer's disease, and highlights the potential of targeting NRP1 to prevent neurological complications like brain fog following COVID-19.